The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

被引:164
|
作者
Cheng, Ying [1 ]
Bai, Feng [2 ]
机构
[1] Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; tau; mitochondrial transport; mitochondrial dynamics; mitochondrial dysfunction; AXONAL-TRANSPORT DEFECTS; OXIDATIVE STRESS; PHOSPHORYLATED TAU; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; HYPERPHOSPHORYLATED TAU; SYNAPTIC DYSFUNCTION; ABNORMAL INTERACTION; MOUSE MODEL; PROTEIN-TAU;
D O I
10.3389/fnins.2018.00163
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a recognized role in the pathophysiology of AD. In recent years, mitochondrial dysfunction has been strongly associated with tau pathology in AD. Overexpression of hyperphosphorylated and aggregated tau appears to damage the axonal transport, leading to abnormal mitochondrial distribution. In addition, pathological tau impairs mitochondrial dynamics by regulating mitochondrial fission/fusion proteins, and further causes mitochondrial dysfunction and neuronal damage. Moreover, mitochondrial dysfunction is also involved in promoting tau pathology in AD. In this article, we evaluate the relationship between phosphorylated tau and mitochondrial dysfunction in AD.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] CoQ10 and Mitochondrial Dysfunction in Alzheimer's Disease
    Fisar, Zdenek
    Hroudova, Jana
    ANTIOXIDANTS, 2024, 13 (02)
  • [32] Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer's Disease
    Zhao, Yuanxin
    Liu, Buhan
    Wang, Jian
    Xu, Long
    Yu, Sihang
    Fu, Jiaying
    Yan, Xiaoyu
    Su, Jing
    BIOMEDICINES, 2022, 10 (08)
  • [33] The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease
    Guha, Sanjib
    Johnson, Gail V. W.
    Nehrke, Keith
    MOLECULAR NEUROBIOLOGY, 2020, 57 (12) : 5103 - 5120
  • [34] Synaptic Dysfunction in Alzheimer’s Disease: Aβ, Tau, and Epigenetic Alterations
    Ke Li
    Qing Wei
    Fang-Fang Liu
    Fan Hu
    Ao-ji Xie
    Ling-Qiang Zhu
    Dan Liu
    Molecular Neurobiology, 2018, 55 : 3021 - 3032
  • [35] Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
    Gao, Yu
    Tan, Lin
    Yu, Jin-Tai
    Tan, Lan
    CURRENT ALZHEIMER RESEARCH, 2018, 15 (03) : 283 - 300
  • [36] Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease
    Li, Yun
    Xia, Xiaohuan
    Wang, Yi
    Zheng, Jialin C.
    JOURNAL OF NEUROINFLAMMATION, 2022, 19 (01)
  • [37] The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment
    Reiss, Allison B.
    Ahmed, Saba
    Dayaramani, Christopher
    Glass, Amy D.
    Gomolin, Irving H.
    Pinkhasov, Aaron
    Stecker, Mark M.
    Wisniewski, Thomas
    De Leon, Joshua
    EXPERIMENTAL GERONTOLOGY, 2022, 164
  • [38] Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies
    Rawat, Priyanka
    Sehar, Ujala
    Bisht, Jasbir
    Selman, Ashley
    Culberson, John
    Reddy, P. Hemachandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [39] Tau Ubiquitination in Alzheimer's Disease
    Li, Longfei
    Jiang, Yanli
    Wang, Jian-Zhi
    Liu, Rong
    Wang, Xiaochuan
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [40] Effects of Redox Homeostasis and Mitochondrial Damage on Alzheimer's Disease
    Wu, Yi-Hsuan
    Hsieh, Hsi-Lung
    ANTIOXIDANTS, 2023, 12 (10)